PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population
Abstract
Authors
V. Schabert S.R. Gandra C. Watson K.M. Fox J. Yeaw S. Goodman S. Milev D.J. Harrison